Article Details
Retrieved on: 2024-05-07 10:55:18
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses Van ECK Associates Corp's reduced stake in Organon & Co., a company involved in women's health solutions, within the context of equity securities and stock market activities. The text also mentions Organon's financial performance, dividend announcement, and insider transactions, which are of interest to shareholders and those following corporate finance and development. The ex-dividend date and dividend payout ratio are specific details of relevance to investors considering stock performance and dividend income.
Article found on: www.marketbeat.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here